NDC 53666-403-33 - Alka Seltzer
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53666-403
- Requested NDC
- 53666-403-33
- Package NDCs from labels
- 53666-403-33, 53666-403-15
- Manufacturer
- Salimex, S.A. | Bayer de Mexico, S.A. de CV
- Effective date
- 2012-11-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alka Seltzer - Salimex, S.A. | Bayer de Mexico, S.A. de CV | Salimex, S.A. | Bayer de Mexico, S.A. de CV | 2012-11-09 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53666-403-15 | 2021-01-29 | C162847 | 48780-1 | 9855d018-d559-cd31-e053-dbdaa90ab51a | Alka Seltzer |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53666-403-15 | Alka Seltzer | 150 in 1 CASE | TABLET, EFFERVESCENT | 150 | 3 | |
| 53666-403-33 | Alka Seltzer | 12 in 1 BOX | TABLET, EFFERVESCENT | 12 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ANHYDROUS CITRIC ACID | ACTIVE INGREDIENT | XF417D3PSL | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| SODIUM BICARBONATE | ACTIVE INGREDIENT | 8MDF5V39QO | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| ANHYDROUS CITRIC ACID | ACTIVE MOIETY | XF417D3PSL | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 | |
| BICARBONATE ION | ACTIVE MOIETY | HN1ZRA3Q20 | ALKA SELTZER (ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE) TABLET, EFFERVESCENT [SALIMEX, S.A.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Aspirin Low Dose | ASPIRIN | DOLGENCORP, LLC | 7396c97e-8a51-4a21-8208-f13258b5285c | 2026-08-05 | Warnings | R16CO5Y76E |
| Sodium Bicarbonate 5 gr | SODIUM BICARBONATE | TWIN MED LLC | e325d899-d9a6-5adb-e053-2995a90ac861 | 2026-08-04 | Warnings | 8MDF5V39QO |
| Aspirin | ASPIRIN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 3ba0a9f2-062a-401e-82eb-54383a822366 | 2026-07-29 | Warnings | R16CO5Y76E |
| Aspirin 81mg Enteric Coated | ASPIRIN | Cardinal Health 107, LLC | 277723db-3578-4842-92eb-2de325f87649 | 2026-07-28 | Warnings | R16CO5Y76E |
| Aspirin Low Dose Chewable | ASPIRIN | Better Living Brands, LLC | 7afce7b4-c86a-43f7-83cf-15ebffba2f35 | 2026-07-28 | Warnings | R16CO5Y76E |
| Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg | ASPIRIN AND EXTENDED - RELEASE DIPYRIDAMOLE | Par Health USA, LLC | 237a1f63-53ff-47fa-903c-ac6276e594a2 | 2026-07-28 | Warnings, Adverse reactions | R16CO5Y76E |
| DERMFREE INSECT BITE RELIEF | SODIUM BICARBONATE 5% INSECT BITE RELIEF | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 5794886c-0d74-9f35-e063-6394a90a27d8 | 2026-07-27 | Warnings | 8MDF5V39QO |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| Xenleta | LEFAMULIN ACETATE | Meitheal Pharmaceuticals Inc. | eb972ea8-7502-422e-84bb-66cb8e93ca06 | 2026-07-22 | Warnings, Adverse reactions | XF417D3PSL |
| Quality Choice Effervescent Cold Relief - Plus | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Chain Drug Marketing Association | 1f93fe6d-ee21-e323-e063-6394a90a61bf | 2026-07-15 | Warnings | R16CO5Y76E |
| Quality Choice Effervescent Cold Relief - Orange | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Chain Drug Marketing Association | 1f93c815-63c7-bfe0-e063-6394a90ab4a5 | 2026-07-15 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | DOLGENCORP, LLC | 955484a6-2a7a-4b15-a9b4-e888ed5de04c | 2026-07-15 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Geri-Care Pharmaceuticals, Corp | 58941782-362d-4436-b365-e909bdbd29a2 | 2026-07-15 | Warnings | R16CO5Y76E |
| Aspirin Low Dose | ASPIRIN | Major Pharmaceuticals | 44730dfb-5062-4015-924b-c30b6c2b19c2 | 2026-07-13 | Warnings | R16CO5Y76E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Cardinal Health 110, LLC. DBA Leader | f1cd0d59-12a8-4ff2-942a-6faa6907ef05 | 2026-07-13 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Amerisource Bergen | 2c5e80e8-a979-45fb-9297-8ff294280c25 | 2026-07-13 | Warnings | R16CO5Y76E |
| Aspirin | ASPIRIN | Wal-Mart Stores Inc | 8ae16aa2-54bc-4c1a-aa36-93524199a67b | 2026-07-09 | Warnings | R16CO5Y76E |
| Sodium Bicarbonate | SODIUM BICARBONATE | Amneal Pharmaceuticals Private Limited | ac91e834-e693-43a2-829b-56793453e8cc | 2026-07-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| ALKA SELTZER COLD Cold and Headache Maximum Strength Fast Dissolve Orange | ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE | Bayer HealthCare LLC. | 50230cad-3d04-8882-e063-6294a90acf3c | 2026-07-09 | Warnings | R16CO5Y76E |
| Aspirin Regular Strength | ASPIRIN | FOODHOLD U.S.A., LLC | 9e09b4fb-e015-45ea-8b1c-27faf65572aa | 2026-07-09 | Warnings | R16CO5Y76E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.